HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment options in relapsed or refractory Hodgkin disease patients: the mini-BEAM regimen does exist too.

AuthorsMiguel A Canales, Alejandro Martin, Dolores Caballero, Fernando Hernandez-Navarro
JournalBritish journal of haematology (Br J Haematol) Vol. 134 Issue 6 Pg. 645-6 (Sep 2006) ISSN: 0007-1048 [Print] England
PMID16889614 (Publication Type: Comment, Letter)
Chemical References
  • Cytarabine
  • Etoposide
  • Melphalan
  • Carmustine
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Carmustine (therapeutic use)
  • Cytarabine (therapeutic use)
  • Drug Administration Schedule
  • Etoposide (therapeutic use)
  • Hodgkin Disease (drug therapy)
  • Humans
  • Melphalan (therapeutic use)
  • Recurrence
  • Salvage Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: